News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cambridge Research Biochemicals Renews Supply Contract With The Medical Research Council For A Fourth Year


5/20/2014 10:04:41 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

20th May, 2014: Cambridge Research Biochemicals (CRB), offering expertise in the custom supply of research reagents, principally peptides and antibodies, has once again demonstrated customer satisfaction with the extension of an important contract in the medical research field.

CRB, based in the North East of England in Billingham on Teesside, has announced renewal of its contract with UK SBS, formerly known as RCUK Shared Services Centre Ltd (RCUK SSC Ltd) for a fourth year, with the original contract being issued in 2010.

Renewal of this contract is extremely significant to CRB as it not only consolidates the existing relationships with the Medical Research Council (MRC), but also allows the company to continue to enhance and progress relations with new MRC Institutes in addition to exploring avenues into other UK based Research Institutes and Universities. CRB comments that renewal of the contract further strengthens its position as a key supplier of custom-synthesised peptides and bespoke polyclonal and monoclonal antibodies.

Under the new contract, CRB will continue to supply the MRC with custom-synthesised peptides and custom-generated polyclonal and monoclonal antibodies for a further 12 months.

Cambridge Research Biochemicals (CRB) Commercial Director Emily Humphrys said: “This is an important announcement for CRB, as it demonstrates that we are delivering a consistently high level of quality life-science tools to the Medical Research Council.”

“The recent expansion and relocation of CRB and investment of £1M has allowed us to expand the peptide and antibody portfolio offered to the MRC further still. This includes monoclonal antibodies to be generated in our new cell culture suite, in addition to the current selection of highly versatile and top quality research peptide and polyclonal antibody tools. The peptide chemistry operation has also increased capacity, allowing CRB to offer a wider range of targets and more creative and complex modifications.”

“The contract renewal also signifies the progress and commitment to quality that CRB have made over the past four years since the agreement was first established. This is a demanding and competitive field and the renewal of the contract recognises both our dedication to the very highest technical and service standards and furthermore, the trust and confidence that the Medical Research Council has placed in CRB.”

Mike Reilly, Category Manager for UK SBS Ltd, said: “The renewal of this contract illustrates the faith that we have in the excellent work being done by the team at CRB. During the time that we have worked together, they have constantly operated under a high level of professionalism and exhibited an impressive commitment to the quality and ethical standards of the products that they supply to us. We look forward to continuing to develop our relationship in the years to come.”

Cambridge Research Biochemicals

Cambridge Research Biochemicals (www.crbdiscovery.com) is a leading independent producer of custom-made peptide and antibody tools, supplying researchers in the pharmaceutical, life science and academic sectors worldwide. The primary applications of its products are as custom-made, laboratory scale reagents for proof of principal studies within early phase drug discovery and to support biomarker programmes in clinical studies. The company produces all flavours of peptides from simple to modified, stable and radio-labelled to dye labelled from milligrams to gram-scale to the highest levels of purity. CRB also distributes supporting products such as PNA and Europium chelate.

Cambridge Research Biochemicals contact:
Tel: Emily Humphrys on 01642 567182
Email: emily.humphrys@crbdiscovery.com
Website: www.crbdiscovery.com

MRC Laboratory of Molecular Biology
The Medical Research Council (MRC) Laboratory of Molecular Biology (LMB) is one of the world's leading research institutes. Discoveries and inventions developed at the LMB, for example DNA sequencing and methods to determine the structure of proteins, have revolutionised all areas of biology. Its scientists work to advance understanding of biological processes at the molecular level. This information will help us to understand the workings of complex systems, such as the immune system and the brain, and solve key problems in human health.
MRC Laboratory of Molecular Biology contact:
Email: lmb-news@mrc-lmb.cam.ac.uk
Website: http://www2.mrc-lmb.cam.ac.uk/

About UK Shared Business Services and UK SBS Procurement
UK Shared Business Services Ltd (UK SBS) is the new name for RCUK Shared Services Centre Ltd. UK SBS is a not-for-profit organisation, providing expertise and quality shared business services that enables customers to focus resources on their core activities; innovating and transforming their own organisations. UK SBS provide their services to several UK based Research Councils including the MRC, BBSRC and NERC. The Procurement function within UK SBS delivers an end-to-end integrated procurement service that provides clients with the products and services that they require to function as entities. UK SBS Procurement provides a wide range of services and dedicated Category Managers to support specialist and niche requirements such as research consumables, field equipment, complex research equipment and leading edge information technology.

UKSBS Contact:
Email: Mike.Reilly@uksbs.co.uk
Website: www.uksbs.co.uk

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES